This antibody was purified from mouse ascites fluid using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell X63-Ag8.653 with Balb/c mouse splenocyte immunized with PMA activated human neutrophil.
Target:
GPI-80/VNN2
Application Dilute:
FCM: 20 µL (ready for use)
* VAT and and shipping costs not included. Errors and price changes excepted